(WISH) — The Food and Drug Administration has granted Emergency Use Authorization to Roche’s COVID-19 At-Home Test successful an effort to grow the public’s entree to accelerated self-testing options, Roche announced Friday.
The trial uses a nasal swab illustration and provides results wrong 20 minutes for COVID-19 and its known variants of concern, including omicron, Roche said.
Beginning successful January, the trial volition beryllium disposable to acquisition over-the-counter astatine pharmacies and retailers crossed the nation.
The institution has the capableness to nutrient tens of millions of tests per month, Roche said.
© 2021 Circle City Broadcasting I, LLC. | All Rights Reserved.